MECHANISMS OF ALLERGY AND ADULT ASTHMA: Edited by J. Andrew Grant and Enrico HefflerUpdates on treatment options in aspirin exacerbated respiratory diseaseRamos, Courtney L.; Woessner, Katharine M. Author Information Division of Allergy, Asthma and Immunology, Scripps Medical Clinic Group, San Diego, California, USA Correspondence to Katharine M. Woessner, Division of Allergy, Asthma and Immunology, Scripps Medical Clinic Group, San Diego, California, USA. E-mail: [email protected] Current Opinion in Allergy and Clinical Immunology: February 2022 - Volume 22 - Issue 1 - p 49-54 doi: 10.1097/ACI.0000000000000796 Buy Metrics Abstract Purpose of review The aim is to describe why this review is timely and relevant. Acetylsalicylic acid exacerbated respiratory disease (AERD) is a clinically significant disease affecting approximately 7% of all asthmatics or around 1,400,000 persons in the United States alone. A large portion of these patients remain undiagnosed. This review summarizes up to date knowledge on the pathophysiology, treatment opinions and provides an expert opinion on how to approach the AERD patient. Recent findings Findings describe the main themes in the literature covered by the article. Review of the current knowledge in terms of the key cells, cytokines/chemokines contributing to the acquired disease state of AERD. It also provides clinical approach toward the AERD patient with regards to current treatment options. Summary Summary describes the implications of the findings for clinical practice or research. This is an up-to-date review of the current literature, with insight into how to approach the management of an AERD patient. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.